NEW YORK (GenomeWeb) – LifeOmic has signed an agreement with Genomenon to use its Mastermind Genomic Search Engine to streamline clinical interpretation of LifeOmic's genome sequencing data.
Through the partnership, LifeOmic will be able to more efficiently interpret patients' genome sequencing data by tagging disease-causing variants with citations from relevant biomedical studies.
LifeOmic has built an analytical platform with advanced informatics to process and examine a patient's whole genome to decipher the potential value within the data. Genomenon's Mastermind provides researchers with immediate access to published scientific literature, speeding up the variant interpretation process by allowing scientists to choose which variants are likely associated with disease and important for clinical care. Mastermind has already indexed more than 5.5 million scientific articles for every disease, gene, and variant, the company added.
Genomenon was awarded a $1.8 million Small Business Innovation Research grant from the National Institutes of Health in April. At the time, the company said the SBIR funding would be used to expand the Mastermind database with millions of additional articles covering various genetic diseases, with Phase I funds being used to perform concordance testing between Mastermind and current gold-standard references of genomic knowledge, and Phase II focusing on refining applications using Mastermind, including the development of ancillary software to inform patient diagnosis and research discovery